Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA clears Kawasumi's needle safety device:

This article was originally published in Clinica

Executive Summary

Kawasumi Laboratories America has gained US clearance to market its needle safety device for protecting oncology clinicians from Huber needle stick injuries incurred while removing needles from subcutaneous ports. The plastic protection device, called K-Shield, also provides a convenient means for disposing the Huber needle after removal from patients, says the Tampa, Florida-based firm. Kawasumi claims that compared with other types of Huber needle safety devices currently on the market, its product does not discomfort the patient at any time, nor does it present any needle movement during the time of infusion.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068671

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel